BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 12782571)

  • 1. Tumor cell senescence in cancer treatment.
    Roninson IB
    Cancer Res; 2003 Jun; 63(11):2705-15. PubMed ID: 12782571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells.
    Roninson IB; Broude EV; Chang BD
    Drug Resist Updat; 2001 Oct; 4(5):303-13. PubMed ID: 11991684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts.
    Jackson JG; Pereira-Smith OM
    Cancer Res; 2006 Sep; 66(17):8356-60. PubMed ID: 16951143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.
    Trost TM; Lausch EU; Fees SA; Schmitt S; Enklaar T; Reutzel D; Brixel LR; Schmidtke P; Maringer M; Schiffer IB; Heimerdinger CK; Hengstler JG; Fritz G; Bockamp EO; Prawitt D; Zabel BU; Spangenberg C
    Cancer Res; 2005 Feb; 65(3):840-9. PubMed ID: 15705882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation.
    Gewirtz DA; Holt SE; Elmore LW
    Biochem Pharmacol; 2008 Oct; 76(8):947-57. PubMed ID: 18657518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
    Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
    Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of senescence-associated growth inhibitors in the tumor-suppressive function of retinoids.
    Roninson IB; Dokmanovic M
    J Cell Biochem; 2003 Jan; 88(1):83-94. PubMed ID: 12461777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
    Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
    Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression.
    Quereda V; Martinalbo J; Dubus P; Carnero A; Malumbres M
    Oncogene; 2007 Dec; 26(55):7665-74. PubMed ID: 17599058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers.
    Roberson RS; Kussick SJ; Vallieres E; Chen SY; Wu DY
    Cancer Res; 2005 Apr; 65(7):2795-803. PubMed ID: 15805280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.
    Ota H; Tokunaga E; Chang K; Hikasa M; Iijima K; Eto M; Kozaki K; Akishita M; Ouchi Y; Kaneki M
    Oncogene; 2006 Jan; 25(2):176-85. PubMed ID: 16170353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC; Zhang T; Lee LH; Shen S
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell.
    Hattangadi DK; DeMasters GA; Walker TD; Jones KR; Di X; Newsham IF; Gewirtz DA
    Biochem Pharmacol; 2004 Nov; 68(9):1699-708. PubMed ID: 15450935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible cellular senescence induced by prolonged exposure to H2O2 involves DNA-damage-and-repair genes and telomere shortening.
    Duan J; Duan J; Zhang Z; Tong T
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1407-20. PubMed ID: 15833273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of oxidative DNA damage during senescence: the first step toward carcinogenesis?
    Martien S; Abbadie C
    Ann N Y Acad Sci; 2007 Nov; 1119():51-63. PubMed ID: 18056954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence.
    Xin H; Curry J; Johnstone RW; Nickoloff BJ; Choubey D
    Oncogene; 2003 Jul; 22(31):4831-40. PubMed ID: 12894224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p31comet Induces cellular senescence through p21 accumulation and Mad2 disruption.
    Yun M; Han YH; Yoon SH; Kim HY; Kim BY; Ju YJ; Kang CM; Jang SH; Chung HY; Lee SJ; Cho MH; Yoon G; Park GH; Kim SH; Lee KH
    Mol Cancer Res; 2009 Mar; 7(3):371-82. PubMed ID: 19276188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
    Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell senescence and cancer.
    Mathon NF; Lloyd AC
    Nat Rev Cancer; 2001 Dec; 1(3):203-13. PubMed ID: 11902575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for multiple pathways to cellular senescence.
    Sasaki M; Honda T; Yamada H; Wake N; Barrett JC; Oshimura M
    Cancer Res; 1994 Dec; 54(23):6090-3. PubMed ID: 7954452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.